Advances in Cancer Research
Published on 14. May 2014
296 pages
978-0-08-049022-9 (ISBN)
Description
Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here once again, outstanding and original reviews are presented.
- New Paradigms for the Treatment of Cancer: The Role of Anti-aiogenesis Agents
- The Hepatocyte Growth Factor/Met Pathway in Development, Tumorigenesis, and B-Cell Differentiation
- Clinical Targets for Anti-metastasis Therapy
- Animal Models of Melanoma: Recent Advances and Future Prospects
- The Indispensable Role of Microenvironment in the Natural History of Low-Grade B-Cell Neoplasms
- Epstein-Barr Virus Latency: LMP2, a Regulator or Means for Epstein-Barr Birus
- Biochemistry and Pathological Importance of Mucin-Associated Antigens in Gastrointenstinal Neoplasia
- Studies on Polyomavirus Persistence and Polyomavirus-Induced Tumor Development in Relation to the Immune System
More details
Series
Language
English
Place of publication
San Diego
United States
Product notice
Windows
ISBN-13
978-0-08-049022-9 (9780080490229)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
George F. Vande Woude | George Klein
Advances in Cancer Research: Volume 79
Book
04/2000
Academic Press
€142.60
Shipment within 15-20 days
Content
- Front Cover
- Advances in CANCER RESEARCH
- Copyright Page
- Contents
- Contributors to Volume 79
- Chapter 1. New Paradigms for the Treatment of Cancer: The Role of Anti-Angiogenesis Agents
- I. Introduction
- II. Growth Factors and Receptor Tyrosine Kinases
- III. Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase
- IV. Matrix Metalloproteinases
- V. Plasminogen Activator/Plasmin System
- VI. Integrins
- VII. Other
- VIII. Conclusions
- References
- Chapter 2. The Hepatocyte Growth Factor/Met Pathway in Development, Tumorigenesis, and B-Cell Differentiation
- I. Introduction
- II. Structure and Function of HGF and Met
- III. HGF/Met in B-Cell Development and Neoplasia
- IV. Summary
- References
- Chapter 3. Clinical Targets for Anti-Metastasis Therapy
- I. Introduction
- II. Metastasis: Clinical and Experimental Considerations
- III. New Tools for Studying the Metastatic Process
- IV. New Insights into the Metastatic Process
- V. Targets for Anti-Metastasis Therapy: Clinical and Biological Considerations
- VI. Conclusions
- References
- Chapter 4. Animal Models of Melanoma: Recent Advances and Future Prospects
- I. Introduction
- II. Clinical Aspects of Melanoma
- III. Molecular Basis for Melanoma
- IV. Role of Receptor Tyrosine Kinases
- V. Model Systems for Melanoma
- VI. Conclusions
- References
- Chapter 5. The Indispensable Role of Microenvironment in the Natural History of Low-Grade B-Cell Neoplasms
- I. Introduction
- II. More Characters Are Coming on the Stage
- III. Conclusions
- References
- Chapter 6. Epstein-Barr Virus Latency: LMP2, A Regulator or Means for Epstein-Barr Virus Persistence?
- I. Introduction
- II. EBV Latency
- III. Latent Membrane Protein 2
- IV. B-Cell Signal Transduction and LMP2A
- V. LMP2A Site-Specific Mutant LCLs
- VI. Model of LMP2A and LMP2B Function in Vitro
- VII. In Vivo Models of LMP2A Function
- VIII. LMP2 Function in Epithelial Cells
- IX. Discussion
- References
- Chapter 7. Biochemistry and Pathological Importance of Mucin-Associated Antigens in Gastrointestinal Neoplasia
- I. Introduction
- II. Biochemistry and Molecular Biology of Mucins
- III. Alterations of Mucin Peptide and Mucin Glycosylation during Carcinogenesis
- IV. Expression of Mucin-Associated Antigens in Gastric Tissues
- V. Expression in Colorectal Tissues
- VI. Prognostic Relevance in Gastrointestinal Cancer
- VII. Serum Tumor Markers (Circulating Antigens)
- VIII. Functional Aspects Regarding Invasion and Metastasis
- IX. Perspectives in Tumor Immunology and Cancer Therapy
- References
- Chapter 8. Studies on Polyomavirus Persistence and Polyomavirus-Induced Tumor Development in Relation to the Immune System
- I. Introduction
- II. Initial Studies on Polyomavirus Infection and Polyoma-Specific Immune Reponses in Vivo and in Vitro
- III. Molecular Characteristics of Polyomavirus
- IV. Polyomavirus Tumor-Specific Transplantation Antigens
- V. Factors Influencing Polyomavirus Persistence and Polyomavirus-Induced Tumor Development
- VI. Studies on Polyomavirus Persistence and Polyomavirus-Induced Tumor Development in Immunocompetent and Immunodeficient Mice
- VII. Concluding Remarks
- VIII. Future Prospects
- References
- Index
